Caprock Group LLC Invests $200,000 in DaVita Inc. (NYSE:DVA)

Caprock Group LLC acquired a new stake in DaVita Inc. (NYSE:DVA) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,339 shares of the company’s stock, valued at approximately $200,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock valued at $99,846,000 after buying an additional 92,014 shares during the period. KBC Group NV lifted its holdings in DaVita by 0.8% in the fourth quarter. KBC Group NV now owns 316,155 shares of the company’s stock valued at $47,281,000 after acquiring an additional 2,636 shares during the last quarter. BNP Paribas Financial Markets increased its stake in DaVita by 23.9% during the third quarter. BNP Paribas Financial Markets now owns 292,039 shares of the company’s stock worth $47,874,000 after acquiring an additional 56,389 shares during the last quarter. Nordea Investment Management AB raised its position in DaVita by 4.9% in the fourth quarter. Nordea Investment Management AB now owns 264,535 shares of the company’s stock valued at $39,712,000 after purchasing an additional 12,339 shares during the period. Finally, abrdn plc lifted its stake in shares of DaVita by 1.2% in the 3rd quarter. abrdn plc now owns 189,065 shares of the company’s stock valued at $30,719,000 after purchasing an additional 2,180 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Barclays boosted their price objective on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $161.80.

DaVita Trading Up 0.8 %

DVA opened at $173.45 on Friday. DaVita Inc. has a 52 week low of $108.76 and a 52 week high of $179.60. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. The business has a fifty day simple moving average of $160.59 and a 200-day simple moving average of $156.34. The firm has a market cap of $14.22 billion, a P/E ratio of 18.71, a P/E/G ratio of 0.86 and a beta of 0.94.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.